13F Holdings
中文EN

MPT MEDICAL PROPERTIES TRUST INC

Real Estate Investment Trusts · NYSE · SEC CIK 1287865 · Fiscal year ends 12/31

Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.5%
TTM net income YoY92.4%
TTM EPS YoY92.4%
Revenue 3-yr CAGR-12.3%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin-12.6%
FCF margin—
EBITDA margin—

Returns

ROE-2.7%
ROA-0.9%
ROIC (approx.)—
Asset turnover0.07x

Leverage & solvency

Liabilities / assets69.2%
Debt / equity2.13x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.72x
Accruals ratio-2.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-302024Q22024-06-30
Income statement
Revenue$252.06M$270.34M$237.52M$240.36M$223.80M$231.84M$225.83M$266.56M
Cost of revenue$97.33M$11.43M-$22.29M$19.76M$81.41M$21.13M$7.84M$4.32M
SG&A expense$32.20M$24.59M$37.73M$26.20M$41.91M$28.49M$36.62M$35.33M
Interest expense$133.33M$132.46M$132.40M$129.71M$115.80M$101.47M$106.24M$101.43M
Pretax income$285,000$26.10M-$66.58M-$88.27M-$108.58M-$402.76M-$791.90M-$305.10M
Income tax-$32.82M$8.51M$10.87M$9.80M$9.44M$9.56M$9.03M$14.56M
Net income$32.83M$17.31M-$77.73M-$98.36M-$118.28M-$412.85M-$801.16M-$320.63M
EPS (basic)0.05—-0.13-0.16-0.20—-1.34-0.54
EPS (diluted)0.05—-0.13-0.16-0.20—-1.34-0.54
Dividends declared per share0.090.090.080.080.080.080.080.30
Weighted avg. shares (diluted)597.72M—601.14M600.81M600.59M—600.23M600.06M
Balance sheet
Cash & equivalents$425.00M$540.86M$396.58M$509.83M$673.48M$332.33M$275.62M$606.55M
Total assets$14.76B$15.00B$14.92B$15.15B$14.85B$14.29B$15.24B$16.19B
Long-term debt$9.66B$9.70B$9.62B$9.65B$9.47B$8.85B$9.22B$9.37B
Total debt$9.66B$9.70B$9.62B$9.65B$9.47B$8.85B$9.22B$9.37B
Total liabilities$10.22B$10.39B$10.26B$10.32B$10.09B$9.46B$9.80B$10.00B
Shareholders' equity$4.54B$4.61B$4.66B$4.83B$4.76B$4.83B$5.44B$6.19B
Net debt$9.24B$9.16B$9.22B$9.14B$8.79B$8.52B$8.94B$8.76B
Shares outstanding597.72M597.01M601.14M600.81M600.60M600.40M600.23M600.06M
Cash flow statement
Operating cash flow-$14.26M$160.06M$18.57M$51.75M$384,000$76.69M$59.20M$35.26M
Investing cash flow-$76.78M-$7.87M-$95.14M-$72.32M-$89.42M$91.74M$143.75M$1.20B
Financing cash flow-$23.22M-$8.98M-$34.46M-$154.80M$426.32M-$99.81M-$548.13M-$853.52M
Depreciation & amortization$73.35M$69.67M$66.99M$66.72M$65.43M$66.20M$204.88M$102.24M
Stock-based compensation$573,000-$5.12M$12.34M$857,000$17.66M$2.40M$14.43M$8.52M

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.